Consolidated income statement For the year ended 31 December 2017 2017 2016 Total before Exceptional Total before Exceptional exceptional and other exceptional and other and other items and other items million Notes items note 9 Total items note 9 Total Revenue 6 931.7 931.7 926.4 926.4 Cost of sales 492.2 492.2 485.9 485.9 Gross profit 439.5 439.5 440.5 440.5 Other operating costs 347.4 49.2 396.6 332.3 15.2 347.5 Operating profit loss 5,9 92.1 49.2 42.9 108.2 15.2 93.0 Finance income 7 0.1 0.1 0.2 0.2 Finance cost 7 20.3 20.3 20.0 20.0 Profit loss before taxation 71.9 49.2 22.7 88.4 15.2 73.2 Taxation 9,11 14.0 8.1 5.9 11.8 7.8 19.6 Profit loss for the year 57.9 41.1 16.8 76.6 23.0 53.6 Profit loss for the year attributable to owners of the Parent 57.9 41.1 16.8 76.6 23.0 53.6 Earnings per share in pence per share basic 12 14.4 10.2 4.2 19.2 5.8 13.4 diluted 12 14.4 10.2 4.2 19.1 5.8 13.3 The notes on pages 115 to 142 form an integral part of these financial statements.
1 11 10 0 Spire Healthcare Group p lc Annual Report 2017 Strategic Report Governance Financial statements Other information Consolidated statement of comprehensive income For the year ended 31 December 2017 million 2017 2016 Profit for the year 16.8 53.6 Other comprehensive income for the year Total comprehensive income for the year attributable to owners of the Parent 16.8 53.6 The notes on pages 115 to 142 form an integral part of these financial statements.
111 111 S Spi pirr e H e He ea al lt th hc ca ar re e G Gr ro ou up p p pl lc Annu c Annua al Re l Repo por rtt 2 2017 017 Consolidated statement of changes in equity For the year ended 31 December 2017 Share Share Capital EBT share Retained Total million Notes capital premium reserves reserves earnings equity As at 1 January 2016 4.0 826.9 376.1 5.6 203.8 997.6 Profit for the year 53.6 53.6 Other comprehensive income for the year Dividend paid 24 14.8 14.8 Share based payments 21 0.4 0.4 Corporation tax on share based payments 0.6 0.6 Deferred tax on share based payments 0.3 0.3 Purchase of shares held in the EBT 19 1.8 1.8 Utilisation of EBT shares for Directors 19 5.2 5.2 Share Bonus Award As at 1 January 2017 4.0 826.9 376.1 2.2 169.5 1,035.3 Profit for the year 16.8 16.8 Other comprehensive income for the year Dividend paid 24 15.2 15.2 Share based payments 21 1.0 1.0 Utilisation of EBT shares for 2014 LTIP Award 19 1.3 1.3 Balance at 31 December 2017 4.0 826.9 376.1 0.9 168.2 1,037.9 The notes on pages 115 to 142 form an integral part of these financial statements.
11 112 2 Spire Healthcare Group p lc Annual Report 2017 Strategic Report Governance Financial statements Other information Consolidated balance sheet As at 31 December 2017 million Notes 2017 2016 ASSETS Non-current assets Property, plant and equipment 13 1,036.9 991.5 Intangible assets 14 517.8 517.8 1,554.7 1,509.3 Current assets Inventories 16 30.1 28.1 Trade and other receivables 17 104.5 119.1 Cash and cash equivalents 18 39.2 67.9 173.8 215.1 Non-current assets held for sale 4 5.6 179.4 215.1 Total assets 1,734.1 1,724.4 EQUITY AND LIABILITIES Equity Share capital 19 4.0 4.0 Share premium 826.9 826.9 Capital reserves 19 376.1 376.1 EBT share reserves 19 0.9 2.2 Retained earnings 168.2 169.5 Equity attributable to owners of the Parent 1,037.9 1,035.3 Total equity 1,037.9 1,035.3 Non-current liabilities Borrowings 20 498.0 495.7 Deferred tax liabilities 11 72.6 71.2 570.6 566.9 Current liabilities Provisions 22 17.9 16.7 Borrowings 20 4.0 4.5 Trade and other payables 23 101.5 100.3 Income tax payable 2.2 0.7 125.6 122.2 Total liabilities 696.2 689.1 Total equity and liabilities 1,734.1 1,724.4 These Consolidated financial statements and the accompanying notes were approved for issue by the Board on 1 March 2018 and signed on its behalf by: Justin Ash Chief Executive Officer Simon Gordon Chief Financial Officer The notes on pages 115 to 142 form an integral part of these financial statements.
1 113 13 S Spi pirr e H e He ea al lt th hc ca ar re e G Gr ro ou up p p pl lc Annu c Annua al Re l Repo por rtt 2 2017 017 Consolidated statement of cash flows For the year ended 31 December 2017 million Notes 2017 2016 Cash flows from operating activities Profit before taxation 22.7 73.2 Adjustments for: Depreciation 13 57.4 51.9 Impairment of property, plant and equipment 13 10.3 0.5 Reversal of impairment on property, plant and equipment 13 1.9 Loss on disposal of property plant and equipment 5 0.4 10.8 Write-off intangible assets 14 1.3 Finance income 7 0.1 0.2 Finance costs 7 20.3 20.0 Share based payments 21 1.0 0.4 112.0 156.0 Movements in working capital: Decrease in trade and other receivables 14.6 15.6 Increase decrease in inventories 2.0 0.9 Increase in trade and other payables 1.3 6.8 Increase in provisions 1.2 1.1 Cash generated from operations 127.1 180.4 Income tax received 1.4 Income tax paid 3.1 4.4 Net cash from operating activities 124.0 177.4 Cash flows from investing activities Interest received 0.1 0.2 Purchase of property plant and equipment 119.2 149.5 Proceeds on disposal of property plant and equipment 0.8 0.6 Net cash used in investing activities 118.3 149.9 Cash flows from financing activities Interest paid 18.8 21.5 Repayment of bank borrowing 0.4 0.4 Purchase of shares held in the EBT 1.8 Dividends paid to equity holders of the Parent 24 15.2 14.8 Net cash used in financing activities 34.4 38.5 Net decrease in cash and cash equivalents 28.7 11.0 Cash and cash equivalents at 1 January 67.9 78.9 Cash and cash equivalents at 31 December 18 39.2 67.9 Exceptional and other items Exceptional and other items paid included in the cash flow 31.3 5.9 Total exceptional and other items 9 49.2 15.2 The notes on pages 115 to 142 form an integral part of these financial statements.
11 114 4 Spire Healthcare Group p lc Annual Report 2017
